# Spore.Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spore-bio

- Industry: Biotechnology
- Headquarters: Paris, France
- Website: www.spore.bio
- Total disclosed funding: $23M
- Latest round: Series A (Feb 20, 2025)
- Investors on record: 6

## About

Based in Paris, France, and founded in 2023 by Amine Raji (CEO), Maxime Mistretta, and Mohamed Tazi, Spore.Bio operates as a microbiology technology company that provides research and development services. In January 2026, Spore.Bio?received a grant?funding?from Google Foundation.
The company specializes in advancing microbiology and engages in the development of solutions that leverage photonic and machine learning technology.
The company plans to use the January 2026 funding to create open-access datasets, share research results, and work together with academic and clinical collaborators to confirm its methods.

## Funding rounds

- Series A, Feb 20, 2025, $23M — LocalGlobe, Point72 Asset Management, STATION F, Singular, Famille C Venture, No Label Ventures

## Investors

- LocalGlobe (https://capitalatlas.ai/funds/localglobe) — Series A
- Point72 Asset Management — Series A
- STATION F — Series A
- Singular (https://capitalatlas.ai/funds/singular) — Series A
- Famille C Venture (https://capitalatlas.ai/funds/famille-c-venture) — Series A
- No Label Ventures (https://capitalatlas.ai/funds/no-label-ventures) — Series A